PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 25.6 EUR 1.59%
Market Cap: 306.9m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

PharmaSGP Holding SE
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Capital Expenditures Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Capital Expenditures
-€866k
CAGR 3-Years
1%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Capital Expenditures
-$590k
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Capital Expenditures
-€2.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
Merck KGaA
XETRA:MRK
Capital Expenditures
-€2.2B
CAGR 3-Years
-11%
CAGR 5-Years
-16%
CAGR 10-Years
-16%
MPH Health Care AG
XETRA:93M1
Capital Expenditures
-€4.7k
CAGR 3-Years
-2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Capital Expenditures
-€41.7m
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Capital Expenditures?
Capital Expenditures
-866k EUR

Based on the financial report for Dec 31, 2023, PharmaSGP Holding SE's Capital Expenditures amounts to -866k EUR.

What is PharmaSGP Holding SE's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-26%

Over the last year, the Capital Expenditures growth was -10%. The average annual Capital Expenditures growth rates for PharmaSGP Holding SE have been 1% over the past three years , -26% over the past five years .

Back to Top